Cyclosporine-treated renal transplant patients have only partial inhibition of calcineurin phosphatase activity.
Batiuk
T D
TD
Department of Medicine, University of Alberta, Edmonton, Canada.
Pazderka
F
F
Halloran
P F
PF
D019703:Calcineurin; D002148:Calmodulin-Binding Proteins / Q000037:antagonists & inhibitors* / Q000097:blood; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D007962:Leukocytes / Q000201:enzymology; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors* / Q000097:blood; D012016:Reference Values
D002148:Calmodulin-Binding Proteins; D016572:Cyclosporine; D019703:Calcineurin; D010749:Phosphoprotein Phosphatases